IMT

Clinical trials for IMT explained in plain language.

Never miss a new study

Get alerted when new IMT trials appear

Sign up with your email to follow new studies for IMT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Lifeline for cancer patients: continued access to targeted drug crizotinib

Disease control Ongoing

This study offers continued access to the drug crizotinib for people with certain cancers (NSCLC, ALCL, or IMT) who are already benefiting from it in another Pfizer study that is ending. About 27 participants will be enrolled to receive ongoing treatment and to monitor safety. Th…

Matched conditions: IMT

Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control

Last updated May 20, 2026 11:55 UTC

IMT

Get alerted when new IMT trials appear

Lifeline for cancer patients: continued access to targeted drug crizotinib